These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 17433898)

  • 1. Hyperhomocysteinemia and venous thrombosis.
    Gatt A; Makris M
    Semin Hematol; 2007 Apr; 44(2):70-6. PubMed ID: 17433898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine and venous thrombosis.
    Quéré I; Gris JC; Dauzat M
    Semin Vasc Med; 2005 May; 5(2):183-9. PubMed ID: 16047270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine, folate and vitamin B(12) in puerperal cerebral venous thrombosis.
    Nagaraja D; Noone ML; Bharatkumar VP; Christopher R
    J Neurol Sci; 2008 Sep; 272(1-2):43-7. PubMed ID: 18617193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia: clinical and therapeutical involvement in venous thrombosis.
    Hoţoleanu C; Porojan-Iuga M; Rusu ML; Andercou A
    Rom J Intern Med; 2007; 45(2):159-64. PubMed ID: 18333369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperhomocysteinemia as a risk factor for venous thrombosis].
    Willems HP; den Heijer M; Blom HJ; Gerrits WB; Rosendaal FR; Bos GM
    Ned Tijdschr Geneeskd; 1999 Mar; 143(11):552-6. PubMed ID: 10321272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Homocysteine and cerebrovascular disease].
    Sepúlveda-Sánchez JM; Matía-Francés R; Martínez-Salio A; González-de la Aleja-Tejera J; Rodríguez-Peña Marín M; Porta-Etessam J
    Rev Neurol; 2004 Feb 16-29; 38(4):347-58. PubMed ID: 14997460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
    Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
    J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic determinants of plasma total homocysteine.
    Gellekink H; den Heijer M; Heil SG; Blom HJ
    Semin Vasc Med; 2005 May; 5(2):98-109. PubMed ID: 16047263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia and venous thrombosis: a meta-analysis.
    den Heijer M; Rosendaal FR; Blom HJ; Gerrits WB; Bos GM
    Thromb Haemost; 1998 Dec; 80(6):874-7. PubMed ID: 9869152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinaemia as a risk factor for deep-vein thrombosis.
    Unlü Y; Keleş S; Becit N; Koçoğullari CU; Koçak H; Bakan E
    Eur J Vasc Endovasc Surg; 2005 Sep; 30(3):315-8. PubMed ID: 15963742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild hyperhomocysteinemia and low folate concentrations as risk factors for cervical arterial dissection.
    Arauz A; Hoyos L; Cantú C; Jara A; Martínez L; García I; Fernández Mde L; Alonso E
    Cerebrovasc Dis; 2007; 24(2-3):210-4. PubMed ID: 17596690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinemia and deep vein thrombosis in orthotopic heart transplantation: a case report.
    Costea A; Bhat G
    Am J Hematol; 2004 Oct; 77(2):161-3. PubMed ID: 15389901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma homocysteine cutoff values for venous thrombosis.
    Castañon MM; Lauricella AM; Kordich L; Quintana I
    Clin Chem Lab Med; 2007; 45(2):232-6. PubMed ID: 17311514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma homocysteine, MTHFR gene mutation, and open-angle glaucoma.
    Clement CI; Goldberg I; Healey PR; Graham SL
    J Glaucoma; 2009 Jan; 18(1):73-8. PubMed ID: 19142139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population--results from the HUNT 2 study.
    Naess IA; Christiansen SC; Romundstad PR; Cannegieter SC; Blom HJ; Rosendaal FR; Hammerstrøm J
    Br J Haematol; 2008 May; 141(4):529-35. PubMed ID: 18318759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
    Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
    Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine, B-vitamins and CVD.
    McNulty H; Pentieva K; Hoey L; Ward M
    Proc Nutr Soc; 2008 May; 67(2):232-7. PubMed ID: 18412997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis.
    Pathare A; Alkindi S; Albalushi T; Bayoumi R; Dennison D; Muralitharan S
    Clin Lab Haematol; 2004 Apr; 26(2):143-6. PubMed ID: 15053809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
    Jakubowski H
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound heterozygosity for the C677T and A1298C mutations of the MTHFR gene in a case of hyperhomocysteinemia with recurrent deep thrombosis at young age.
    Jurcuţ R; Pop I; Coriu D; Grasu M; Zilişteanu D; Giuşcă S; Ginghină C
    Rom J Intern Med; 2008; 46(3):255-9. PubMed ID: 19366086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.